Developer docs
API playgroundTry for free, no card

Search company profiles

Optalert

Full company profile

uuid000cvxb

Namestring
Optalert
Legal namestring
OPTALERT Australia Pty Ltd
Websiteurl
optalert.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Optalert is an Australian medical-technology company, founded in 2002 by sleep medicine pioneer Dr. Murray Johns AM, that develops scientifically validated drowsiness and impairment detection systems based on blepharometry — the precise measurement and analysis of eyelid movements pioneered by its founder. The patented Johns Drowsiness Scale (JDS) processes 64 characteristics of eyelid blink signals to output a continuous 0.0–10.0 impairment score, with the complementary Optalert Intoxication Scale (OIS) detecting alcohol-related impairment at low BAC levels; the biomarker has been validated in over 140 peer-reviewed publications and deemed 'commensurate with gold standard laboratory measures' by Harvard Medical School.\n\nThe company operates three solution lines. For mining and transport fleets, Optalert sells the Eagle Suite — industrial-grade wearable glasses with a 500 fps sensor, ruggedized industrial tablets, the IRIS cloud monitoring platform, the Eagle Eye fleet dashboard, and Eagle Insights for AI-generated reporting — deployed with enterprise customers such as Vale and BHP across haul truck and maintenance operations. For automotive, Optalert licenses the JDS/OIS algorithms via a Software Development Kit to OEMs and Tier 1 DMS developers to enable GSR and Euro NCAP compliance; in April 2026 the JDS technology entered mass production with a leading European OEM. For neurology, the company offers the Owl Eye App for non-invasive obstructive sleep apnoea screening (pursuing SaMD classification) and conducts biomarker research into Alzheimer's, Parkinson's, epilepsy, and traumatic brain injury.\n\nOptalert monetises through a hybrid enterprise model: hardware sales or monthly rentals for Eagle Suite, recurring software licence and subscription fees, professional and fatigue-risk-profiling services, extended warranty, and OEM/Tier 1 SDK licensing royalties. Its go-to-market combines direct enterprise field sales for mining and transport fleets, an API/SDK-first motion for automotive DMS developers, and content-led demand generation via its website and case studies. The company is privately held, headquartered in Cremorne, Melbourne (Australia), with disclosed operating presence in Australia, Brazil, and Chile and a commercial European OEM relationship.\n

Short descriptiontext

Optalert is an Australian MedTech company that builds scientifically validated drowsiness and impairment detection technology based on eyelid movement analysis, serving mining and transport fleets, automotive OEMs, and neurology researchers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCremorne, Australia
HQ citystring
Cremorne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
drowsiness detection systems, driver monitoring systems, fatigue management software, automotive safety algorithms, blepharometry eye tracking
Industry2 codes
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHAJAC
Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
NAICS code1 code
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Measuring & Controlling Devices, Nec3829
Product category
Driver Monitoring and Fatigue Management Software
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Automotive SDK Licensing
TypeLicensing Royalties
Description

Optalert licenses its impairment detection software (JDS algorithm and OIS) to automotive manufacturers to integrate into their driver monitoring systems. This enables GSR and Euro NCAP compliance testing and validation. Revenue generated through licensing agreements with OEMs and Tier 1 suppliers.

optalert.com
2Hardware Sales - Eagle Suite
TypeHardware Sales
Description

Sale of fatigue monitoring hardware including Eagle Glasses with 500 fps sensors, Eagle Industrial ruggedized tablets, and associated equipment for real-time drowsiness monitoring in mining and transport fleets.

optalert.com
3Software Licensing and Subscription
TypeSubscription Recurring
Description

Non-exclusive, non-transferable license to use the Software (OPTALERT vehicle operating system and algorithm) during the contract term. Includes Ongoing Licence Fee for continued access, Maintenance Releases, and Upgrades. Subscription model with monthly rental fees.

optalert.com
4Professional Services
TypeProfessional Services
Description

Implementation services (Implementation Fee), Training Services, Customer Support Services, Fatigue Risk Profiler Services, Reporting Services, and Additional Services including data analysis consultancy.

optalert.com
5Extended Warranty
TypeSubscription Recurring
Description

Extended Warranty Fee for additional warranty coverage beyond the standard 12-month warranty period.

optalert.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Custom Enterprise Pricing
ModelHybridBilling cadenceMonthly
Notes

Product Fees (purchase price for fatigue monitoring system comprising Hardware and Software), Rental Fee (monthly rental for equipment), Implementation Fee, Ongoing Licence Fee, Ongoing Reporting Services Fee, Ongoing Fatigue Risk Profiler Services Fee, and Upgrade Fees. All fees specified in Technical Proposal or Sales Order. Rental Fee is payable monthly even if Product is not used.

optalert.com
2DMS Validation Assessment
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Initial assessment of 5 files or 180 minutes of data is complimentary. Full report beyond the free tier is charged at USD$10 per minute of data assessed.

optalert.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1Eagle Suite
Description

Mining and transport fleet fatigue management product line, comprising Eagle Glasses, Eagle Industrial, Eagle Light, Eagle Eye dashboard, Eagle Insights, and IRIS cloud-based monitoring platform.

optalert.com
+5 more records
Core offering1 text field

Optalert develops and licenses scientifically validated drowsiness and impairment detection technology built on blepharometry (eyelid movement analysis). Its flagship Johns Drowsiness Scale (JDS) algorithm and Optalert Intoxication Scale (OIS) are delivered to mining and transport fleets through the Eagle Suite hardware/software platform, and to automotive OEMs and DMS developers through a licensable SDK. The company also offers the Owl Eye App for obstructive sleep apnoea screening and pursues neurological biomarker research.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • Up to 98% reduction in fatigue risk exposure in mining operations
+8 more records
Product overview1 text field

Optalert is a pioneering Australian MedTech company offering scientifically validated drowsiness and impairment detection solutions across three sectors: Mining & Transport (Eagle Suite), Automotive (JDS Algorithm, OIS, Automotive SDK), and Neurology (Owl Eye App, Neurological Biomarker Research). The Eagle Suite provides comprehensive fleet fatigue management combining Eagle Glasses (500 fps wearable sensor), Eagle Industrial/Eagle Light tablets, Eagle Eye dashboard, Eagle Insights AI reporting, and IRIS cloud monitoring. Automotive solutions include the patented Johns Drowsiness Scale (JDS) algorithm and Intoxication Scale (OIS) licensed via SDK to automotive OEMs. Neurology offerings include the Owl Eye OSA screening app and research into neurological biomarkers. The JDS algorithm is the world's only scientifically proven objective drowsiness measure, validated in over 140 peer-reviewed publications, now entering mass production with leading European automotive OEMs.

Product and service5 records
1Eagle Suite
CategoryFleet fatigue management platform
Description

Comprehensive fleet fatigue management platform for mining and transport operations, combining wearable Eagle Glasses, Eagle Industrial tablets, Eagle Light, Eagle Eye dashboard, Eagle Insights AI reporting and the IRIS cloud monitoring system to deliver real-time drowsiness scoring (JDS 0–10), GPS tracking, risk profiling, incident management and predictive trend analysis across entire vehicle fleets.

2Johns Drowsiness Scale (JDS) Algorithm
CategoryDrowsiness detection algorithm / IP
Description

Patented drowsiness detection algorithm that processes 64 characteristics of eyelid blink signals to output a 0.0–10.0 objective drowsiness score spanning from alertness to sleep; detects cognitive impairment up to 20 minutes earlier than non-medically based solutions and is licensed to automotive OEMs and DMS developers for integration into driver monitoring systems.

3Optalert Intoxication Scale (OIS)
CategoryImpairment detection algorithm
Description

Non-invasive eyelid-movement-based alcohol impairment detection that identifies when a driver is dangerously impaired by alcohol, including at lower BAC levels where impairment persists long after BAC begins to decline.

4Automotive SDK
CategoryOEM / developer SDK
Description

Software development kit that licenses Optalert's JDS and OIS impairment detection algorithms to automotive manufacturers for integration into their driver monitoring systems; enables GSR and Euro NCAP compliance testing and validation, integrates into any DMS within days using a single eyelid-movement input signal, and includes sample code, tools, API information and documentation.

5Owl Eye App
CategoryClinical / consumer health screening application
Description

Consumer and clinical application that uses eyelid movement analysis to detect signs of sleep issues and screen for obstructive sleep apnoea (OSA) while the subject is awake; the first non-invasive awake OSA screen of its kind and in the process of pursuing software as a medical device (SaMD) classification.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Vale, one of the world's largest mining companies, has commercially validated Optalert's technology. Optalert's fatigue detection system is deployed across Vale's off-road haulage fleet. This partnership demonstrates Optalert's capability to operate at scale in the mining industry with over 200 trucks monitored.

2Harvard Medical School
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Harvard Medical School has validated Optalert's proprietary JDS biomarker as 'commensurate with gold standard laboratory measures.' This endorsement provides significant credibility for the technology's medical accuracy and scientific validity.

optalert.com
3Leading European Automotive OEM
Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing Partner
Description

Optalert's JDS driver monitoring technology has entered mass production with a leading European OEM. Vehicles fitted with Optalert's JDS algorithm are now rolling off production lines. This represents a significant commercial milestone and validates Optalert's automotive market entry.

optalert.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Australian-listed leader in sleep-disordered breathing treatment (CPAP, sleep apnea devices). Adjacent rather than directly competitive, but relevant to Optalert's Owl Eye OSA-screening business, where Owl Eye could feed at-risk patients into ResMed's diagnostic and treatment pathway.

TypeDirect peer
Description

Canadian fleet telematics leader that acquired SmartCap Technologies, a fatigue-band product directly competing with Optalert's Eagle Suite in mining and heavy-industry fleets. Geotab brings a much larger installed telematics base, making it the most relevant mining-fleet fatigue peer.

TypeBroad incumbent
Description

US-based fleet safety AI company (Driver•i) providing video-based driver behavior monitoring and coaching for commercial fleets. Competes with Optalert's Eagle Suite in the commercial fleet fatigue market via camera-based monitoring, though Optalert's eyelid-based approach is differentiated.

TypeBroad incumbent
Description

US fleet video telematics incumbent with dash-cam-based driver behavior monitoring and fatigue detection. A broader incumbent in commercial fleet safety, overlapping with Optalert's Eagle Suite in transport/logistics customers but using a different sensing modality.

TypeDirect peer
Description

Swedish DMS specialist that supplies eye-tracking software to multiple automotive OEMs and acquired Affectiva to extend into in-cabin sensing. Direct competitor to Optalert's Automotive SDK for JDS algorithm integration, with overlapping Tier 1 customer set and similar GSR/Euro NCAP use cases.

6Cipia Vision
TypeDirect peer
Description

Israeli DMS company (formerly EyeSight Technologies) delivering in-cabin driver monitoring software to automotive OEMs and Tier 1s. Competes head-to-head with Optalert's JDS SDK in the automotive licensing market, with a focus on DMS-as-software delivery models.

TypeDirect peer
Description

Australian-headquartered driver monitoring company providing AI-based eye and face tracking DMS for both automotive OEMs (Guardian, Magna collaborations) and commercial fleets. Direct competitor in both Optalert's automotive SDK and fleet fatigue markets, with the same Australian origin and overlapping mining/fleet customer base.

TypeBroad incumbent
Description

German Tier 1 supplier with an automotive interior monitoring system and DMS offerings. A broad incumbent competing with Optalert in automotive DMS, typically integrating in-cabin cameras rather than licensing a third-party algorithm, and serving the same GSR/Euro NCAP regulatory tailwind.

TypeBroad incumbent
Description

Swedish eye-tracking technology company with broad applications across consumer research, healthcare, and automotive DMS via its Tobii AutoSense unit. A broader incumbent in the same eye-tracking category as Optalert's blepharometry core, but with a wider portfolio and less focus on drowsiness specifically.

TypeBroad incumbent
Description

French Tier 1 automotive supplier offering its own driver monitoring system and in-cabin sensing solutions to OEMs. A broad incumbent that competes with Optalert's automotive licensing at the Tier 1 integration layer, with much larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Optalert

Driver Monitoring and Fatigue Management Softwareoptalert.com

Optalert is an Australian MedTech company that builds scientifically validated drowsiness and impairment detection technology based on eyelid movement analysis, serving mining and transport fleets, automotive OEMs, and neurology researchers.

What Optalert does

Optalert is an Australian medical-technology company, founded in 2002 by sleep medicine pioneer Dr. Murray Johns AM, that develops scientifically validated drowsiness and impairment detection systems based on blepharometry — the precise measurement and analysis of eyelid movements pioneered by its founder. The patented Johns Drowsiness Scale (JDS) processes 64 characteristics of eyelid blink signals to output a continuous 0.0–10.0 impairment score, with the complementary Optalert Intoxication Scale (OIS) detecting alcohol-related impairment at low BAC levels; the biomarker has been validated in over 140 peer-reviewed publications and deemed 'commensurate with gold standard laboratory measures' by Harvard Medical School.\n\nThe company operates three solution lines. For mining and transport fleets, Optalert sells the Eagle Suite — industrial-grade wearable glasses with a 500 fps sensor, ruggedized industrial tablets, the IRIS cloud monitoring platform, the Eagle Eye fleet dashboard, and Eagle Insights for AI-generated reporting — deployed with enterprise customers such as Vale and BHP across haul truck and maintenance operations. For automotive, Optalert licenses the JDS/OIS algorithms via a Software Development Kit to OEMs and Tier 1 DMS developers to enable GSR and Euro NCAP compliance; in April 2026 the JDS technology entered mass production with a leading European OEM. For neurology, the company offers the Owl Eye App for non-invasive obstructive sleep apnoea screening (pursuing SaMD classification) and conducts biomarker research into Alzheimer's, Parkinson's, epilepsy, and traumatic brain injury.\n\nOptalert monetises through a hybrid enterprise model: hardware sales or monthly rentals for Eagle Suite, recurring software licence and subscription fees, professional and fatigue-risk-profiling services, extended warranty, and OEM/Tier 1 SDK licensing royalties. Its go-to-market combines direct enterprise field sales for mining and transport fleets, an API/SDK-first motion for automotive DMS developers, and content-led demand generation via its website and case studies. The company is privately held, headquartered in Cremorne, Melbourne (Australia), with disclosed operating presence in Australia, Brazil, and Chile and a commercial European OEM relationship.\n

Optalert firmographics

Firmographics
Name
Optalert
Legal name
OPTALERT Australia Pty Ltd
Website
https://optalert.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
Optalert is an Australian MedTech company that builds scientifically validated drowsiness and impairment detection technology based on eyelid movement analysis, serving mining and transport fleets, automotive OEMs, and neurology researchers.
Ownership category
akta.pro rank

Optalert industry classification

Industry
Product category
Driver Monitoring and Fatigue Management Software
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Measuring & Controlling Devices, Nec (3829)
akta.pro industry
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHAJAC
Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)

Keywords

  • Drowsiness detection systems
  • Driver monitoring systems
  • Fatigue management software
  • Automotive safety algorithms
  • Blepharometry eye tracking

Where Optalert is headquartered

Location

Headquarters

HQ city
Cremorne
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Optalert business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Automotive SDK Licensing: Optalert licenses its impairment detection software (JDS algorithm and OIS) to automotive manufacturers to integrate into their driver monitoring systems. This enables GSR and Euro NCAP compliance testing and validation. Revenue generated through licensing agreements with OEMs and Tier 1 suppliers.
  2. Hardware Sales - Eagle Suite: Sale of fatigue monitoring hardware including Eagle Glasses with 500 fps sensors, Eagle Industrial ruggedized tablets, and associated equipment for real-time drowsiness monitoring in mining and transport fleets.
  3. Software Licensing and Subscription: Non-exclusive, non-transferable license to use the Software (OPTALERT vehicle operating system and algorithm) during the contract term. Includes Ongoing Licence Fee for continued access, Maintenance Releases, and Upgrades. Subscription model with monthly rental fees.
  4. Professional Services: Implementation services (Implementation Fee), Training Services, Customer Support Services, Fatigue Risk Profiler Services, Reporting Services, and Additional Services including data analysis consultancy.
  5. Extended Warranty: Extended Warranty Fee for additional warranty coverage beyond the standard 12-month warranty period.

Pricing tiers

ModelBillingPrice
HybridMonthlyCustom Enterprise Pricing
Usage-basedPay-as-you-goDMS Validation Assessment

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Optalert product offering

Product offering

Core offering

Optalert develops and licenses scientifically validated drowsiness and impairment detection technology built on blepharometry (eyelid movement analysis). Its flagship Johns Drowsiness Scale (JDS) algorithm and Optalert Intoxication Scale (OIS) are delivered to mining and transport fleets through the Eagle Suite hardware/software platform, and to automotive OEMs and DMS developers through a licensable SDK. The company also offers the Owl Eye App for obstructive sleep apnoea screening and pursues neurological biomarker research.

Product overview

Optalert is a pioneering Australian MedTech company offering scientifically validated drowsiness and impairment detection solutions across three sectors: Mining & Transport (Eagle Suite), Automotive (JDS Algorithm, OIS, Automotive SDK), and Neurology (Owl Eye App, Neurological Biomarker Research). The Eagle Suite provides comprehensive fleet fatigue management combining Eagle Glasses (500 fps wearable sensor), Eagle Industrial/Eagle Light tablets, Eagle Eye dashboard, Eagle Insights AI reporting, and IRIS cloud monitoring. Automotive solutions include the patented Johns Drowsiness Scale (JDS) algorithm and Intoxication Scale (OIS) licensed via SDK to automotive OEMs. Neurology offerings include the Owl Eye OSA screening app and research into neurological biomarkers. The JDS algorithm is the world's only scientifically proven objective drowsiness measure, validated in over 140 peer-reviewed publications, now entering mass production with leading European automotive OEMs.

Differentiator

Problem solved

Functional benefit

Brands

  • Eagle Suite: Mining and transport fleet fatigue management product line, comprising Eagle Glasses, Eagle Industrial, Eagle Light, Eagle Eye dashboard, Eagle Insights, and IRIS cloud-based monitoring platform.
  • Johns Drowsiness Scale (JDS)
  • Optalert Intoxication Scale (OIS)
  • Owl Eye App
  • IRIS
  • Automotive SDK

Products and services

  • Eagle Suite Comprehensive fleet fatigue management platform for mining and transport operations, combining wearable Eagle Glasses, Eagle Industrial tablets, Eagle Light, Eagle Eye dashboard, Eagle Insights AI reporting and the IRIS cloud monitoring system to deliver real-time drowsiness scoring (JDS 0–10), GPS tracking, risk profiling, incident management and predictive trend analysis across entire vehicle fleets.
  • Johns Drowsiness Scale (JDS) Algorithm Patented drowsiness detection algorithm that processes 64 characteristics of eyelid blink signals to output a 0.0–10.0 objective drowsiness score spanning from alertness to sleep; detects cognitive impairment up to 20 minutes earlier than non-medically based solutions and is licensed to automotive OEMs and DMS developers for integration into driver monitoring systems.
  • Optalert Intoxication Scale (OIS) Non-invasive eyelid-movement-based alcohol impairment detection that identifies when a driver is dangerously impaired by alcohol, including at lower BAC levels where impairment persists long after BAC begins to decline.
  • Automotive SDK Software development kit that licenses Optalert's JDS and OIS impairment detection algorithms to automotive manufacturers for integration into their driver monitoring systems; enables GSR and Euro NCAP compliance testing and validation, integrates into any DMS within days using a single eyelid-movement input signal, and includes sample code, tools, API information and documentation.
  • Owl Eye App Consumer and clinical application that uses eyelid movement analysis to detect signs of sleep issues and screen for obstructive sleep apnoea (OSA) while the subject is awake; the first non-invasive awake OSA screen of its kind and in the process of pursuing software as a medical device (SaMD) classification.

Quantifiable outcome

  • Up to 98% reduction in fatigue risk exposure in mining operations
  • +8 more outcomes

Companies that use Optalert

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Optalert technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature8 records

Optalert partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and flagship.

  • ValecoreStrategic or Co-development PartnerVale, one of the world's largest mining companies, has commercially validated Optalert's technology. Optalert's fatigue detection system is deployed across Vale's off-road haulage fleet. This partnership demonstrates Optalert's capability to operate at scale in the mining industry with over 200 trucks monitored.
  • Harvard Medical SchoolcoreStrategic or Co-development PartnerHarvard Medical School has validated Optalert's proprietary JDS biomarker as 'commensurate with gold standard laboratory measures.' This endorsement provides significant credibility for the technology's medical accuracy and scientific validity.
  • Leading European Automotive OEMflagshipOEM/ Whitelabel/ Licensing PartnerOptalert's JDS driver monitoring technology has entered mass production with a leading European OEM. Vehicles fitted with Optalert's JDS algorithm are now rolling off production lines. This represents a significant commercial milestone and validates Optalert's automotive market entry.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Optalert competitors and assessment

Company assessment

Others

  • ResMed: Australian-listed leader in sleep-disordered breathing treatment (CPAP, sleep apnea devices). Adjacent rather than directly competitive, but relevant to Optalert's Owl Eye OSA-screening business, where Owl Eye could feed at-risk patients into ResMed's diagnostic and treatment pathway.

Direct peers

  • Geotab: Canadian fleet telematics leader that acquired SmartCap Technologies, a fatigue-band product directly competing with Optalert's Eagle Suite in mining and heavy-industry fleets. Geotab brings a much larger installed telematics base, making it the most relevant mining-fleet fatigue peer.
  • Smart Eye: Swedish DMS specialist that supplies eye-tracking software to multiple automotive OEMs and acquired Affectiva to extend into in-cabin sensing. Direct competitor to Optalert's Automotive SDK for JDS algorithm integration, with overlapping Tier 1 customer set and similar GSR/Euro NCAP use cases.
  • Cipia Vision: Israeli DMS company (formerly EyeSight Technologies) delivering in-cabin driver monitoring software to automotive OEMs and Tier 1s. Competes head-to-head with Optalert's JDS SDK in the automotive licensing market, with a focus on DMS-as-software delivery models.
  • Seeing Machines: Australian-headquartered driver monitoring company providing AI-based eye and face tracking DMS for both automotive OEMs (Guardian, Magna collaborations) and commercial fleets. Direct competitor in both Optalert's automotive SDK and fleet fatigue markets, with the same Australian origin and overlapping mining/fleet customer base.

Broad incumbents

  • Netradyne: US-based fleet safety AI company (Driver•i) providing video-based driver behavior monitoring and coaching for commercial fleets. Competes with Optalert's Eagle Suite in the commercial fleet fatigue market via camera-based monitoring, though Optalert's eyelid-based approach is differentiated.
  • Lytx: US fleet video telematics incumbent with dash-cam-based driver behavior monitoring and fatigue detection. A broader incumbent in commercial fleet safety, overlapping with Optalert's Eagle Suite in transport/logistics customers but using a different sensing modality.
  • Bosch: German Tier 1 supplier with an automotive interior monitoring system and DMS offerings. A broad incumbent competing with Optalert in automotive DMS, typically integrating in-cabin cameras rather than licensing a third-party algorithm, and serving the same GSR/Euro NCAP regulatory tailwind.
  • Tobii: Swedish eye-tracking technology company with broad applications across consumer research, healthcare, and automotive DMS via its Tobii AutoSense unit. A broader incumbent in the same eye-tracking category as Optalert's blepharometry core, but with a wider portfolio and less focus on drowsiness specifically.
  • Valeo: French Tier 1 automotive supplier offering its own driver monitoring system and in-cabin sensing solutions to OEMs. A broad incumbent that competes with Optalert's automotive licensing at the Tier 1 integration layer, with much larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Optalert social profiles

Digital presence

Optalert financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Optalert leadership team

Management profile

Number of profiles

Profiles5 records

Optalert funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Optalert M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Optalert

What does Optalert do?

Optalert develops and licenses scientifically validated drowsiness and impairment detection technology built on blepharometry (eyelid movement analysis). Its flagship Johns Drowsiness Scale (JDS) algorithm and Optalert Intoxication Scale (OIS) are delivered to mining and transport fleets through the Eagle Suite hardware/software platform, and to automotive OEMs and DMS developers through a licensable SDK. The company also offers the Owl Eye App for obstructive sleep apnoea screening and pursues neurological biomarker research.

Is Optalert a public or private company?

Optalert is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Optalert founded?

Optalert was founded in 2002. It employs 11 to 50 people.

Where is Optalert based?

Optalert is headquartered in Cremorne, Australia, in the Oceania region.

How does Optalert make money?

Five revenue lines are on record. Automotive SDK Licensing is the primary driver. The others are hardware Sales - Eagle Suite, software Licensing and Subscription, professional Services and extended Warranty.

Who are Optalert's main competitors?

ResMed is listed as an others. Direct peers are Geotab, Smart Eye, Cipia Vision and Seeing Machines. Broad incumbents are Netradyne, Lytx, Bosch, Tobii and Valeo.

Does Optalert have an API?

Yes. Optalert offers an Automotive Software Development Kit (SDK) that automotive manufacturers can license to integrate impairment detection algorithms into their driver monitoring systems. The SDK enables GSR and Euro NCAP compliance testing and validation. It requires one input signal (eyelid movements/blinks), processes 64 characteristics, and outputs JDS scores from 0.0 to 10.0. The SDK includes Sample Code, Tools, API Information, and Documentation. Developers must submit an SDK Access Request describing their proposed application for approval.

What industry is Optalert in?

Optalert's product category is Driver Monitoring and Fatigue Management Software. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity). Its NAICS code is 33451 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
JhavtechWhy Cross-Platform App Development is the Future of Mobile AppsJhavtech Studios promotes cross-platform app development as a strategic advantage for businesses, highlighting its cost efficiency and faster time-to-market compared to native development. The article outlines the benefits of using frameworks like Flutter, React Native, and Xamarin, citing potential savings of 30%-40% in costs and 50% faster deployment times. It also details Jhavtech's development process and showcases a success story with Optalert to demonstrate practical application.PR NewswireWearable Devices' Expansion to Industrial Sector Thrives with Addition of Advanced Sensors and SoftwareFrost & Sullivan released a market research report finding that the emergence of the Internet of Things and workers' need for real-time data monitoring are accelerating wearable technology adoption across industrial sectors including manufacturing, logistics, construction, mining, and healthcare. The study identifies key innovators in the space including Epson (UK), ODG (USA), and OptAlert (Australia), which are developing devices such as smart eyewear, fatigue management sensors, and head-mounted displays with augmented reality for industrial applications. Challenges to broader adoption include high capital costs, limited platform support, and concerns about seamless workflow integration.MedCity NewsHow are car manufacturers integrating biometrics into vehicles to monitor health?Frost & Sullivan projects biometric wearables could be in one of three cars by 2025, covering health monitoring like heart rate and fatigue detection. The report cites companies such as Empatica, Gestigon, and Optalert, and notes potential security risks from hacking.